Zealand Pharma
kr 265.90Change from previous close: +4.48%Absolute change: +kr 11.40
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- kr 17.76B
- Enterprise value
- kr 4.41B
- P/E (trailing 12 months)
- 6.79
- Forward P/E
- 35.5
- Price/book
- 1.02
- Price/sales
- 3.82
- EV/EBITDA
- 1.90
- EV/revenue
- 0.95
Profitability and growth
- Gross margin
- 100.0%
- Operating margin
- 85.9%
- Net margin
- 59.0%
- ROE
- 16.3%
- ROA
- 7.8%
- Revenue growth (year over year)
- -50.6%
- Earnings growth (year over year)
- -47.6%
Financial health
- Total cash
- kr 14.46B
- Total debt
- kr 411M
- Debt/equity
- 0.02
- Current ratio
- 14.0
- Quick ratio
- 13.8
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- kr 416.00
- Median price target
- kr 425.00
- High price target
- kr 595.00
- Low price target
- kr 300.00
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- kr 7.49
- EPS estimate, current year
- kr 25.13
Shares and trading
- Beta
- 0.59
- Average volume
- 373.91K
- Shares outstanding
- 66.8M
- Float
- 55.21M
- Institutional ownership
- 40.9%
- Insider ownership
- 0.5%